(Reuters) - Novavax cut its annual revenue forecast on Tuesday, citing lower-than-expected sales of its COVID-19 vaccine, ...

Novavax (NASDAQ:NVAX) shares lost ~12% in the premarket on Tuesday after the Gaithersburg, MD-based biotech, with its Q3 2024 ...

A woman who was fired for refusing to comply with her employer's COVID-19 mandate due to her Catholic faith was awarded over $12 million by a Detroit jury.

Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...

Health departments in Texas, Florida and Michigan that led vaccination campaigns in their communities at the height of the ...

A 55-year-old vaccine conspiracy theorist and COVID-19 denier convicted of encouraging violence over Britain's handling of ...

An opponent of vaccines who wrote social media posts urging violence against scientists, politicians and public health officials during the COVID-19 pandemic has been sentenced to five years in prison ...

On 1, Novavax, Inc. (NASDAQ:NVAX) and the U.K. Health Security Agency, representing the U.K. Secretary of State for Health ...

As of late October, the CDC recommends a second dose of the 2024-2025 COVID-19 vaccine for at-risk groups. Here's what you ...

Researchers investigate how public trust in the science of COVID-19 vaccines has changed in the United States.

Misconception #1: The flu and COVID-19 vaccines can make you sick. "You aren't going to get the flu from the flu vaccine. You ...

Moderna shares jumped after the biotechnology company reported higher-than-expected sales of its Covid-19 vaccine and backed ...